Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer SurgeryTracy Downs(University of Wisconsin Carbone Cancer Center), Edward M. Messing(University of Rochester Medical Center)Cancer Prevention ResearchAugust 27, 202410.1158/1940-6207.capr-24-0194Cited by 2SaveCiteExport RISWatch citationsRelated PapersEvaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial|The Journal of Urology|2019|27